Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study

Table 3 Risk factors for the occurrence of cytomegalovirus symptomatic reactivation

Variables		Univariate analysis		Multivariate analysis
		Occurrence of symptomaticinfection or end-organ disease	P	OR (95%CI)	P
HBcIgG	Positive	16/46 (34%)	< 0.001	8.928 (1.991-33.321)	0.023
	Negative	20/281 (7%)
Diagnosis	MM	16/201 (8%)	0.095	1.841 (1.058-5.633)	0.125
	Lymphoma	20/126 (16%)
Diagnosis of T-cell NHL	Yes	6/19 (31%)	0.022	4.739 (1.511-11.112)	0.042
	No	30/308 (10%)
Median age at transplant	Years (range)	60 (35-71) vs 52 (18-72)	0.004	2.922 (1.273-6.295)	0.088

MM: Multiple myeloma; NHL: Non-Hodgkin’s lymphoma.